284 results
8-K
EX-5.1
INO
Inovio Pharmaceuticals Inc
17 Apr 24
INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
4:04pm
stated. This opinion speaks only as to law and facts in effect or existing as of the date hereof and we undertake no obligation or responsibility
8-K
EX-1.1
INO
Inovio Pharmaceuticals Inc
17 Apr 24
INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
4:04pm
, employees or any other party, (c) no Underwriter has assumed or will assume an advisory or fiduciary responsibility in favor of the Company
424B5
INO
Inovio Pharmaceuticals Inc
17 Apr 24
Prospectus supplement for primary offering
4:02pm
responsibility for the accuracy and completeness of the forward-looking statements. Except as required by law, we are under no obligation to update any … or responsibility in case of any default by us under the applicable warrant agreement or warrant, including any duty or responsibility to initiate any proceedings
8-K
EX-99.1
xl8fbqf
23 Jun 23
Regulation FD Disclosure
4:25pm
S-8
EX-99.3
dat0g7oot
30 Jun 22
Registration of securities for employees
5:08pm